Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension

Aim. To assess the potential of the angiotensin II receptor antagonist losartan for the correction of hyperuricemia (HU) in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. This open, randomised, controlled comparative study in parallel groups included 60 A...

Full description

Bibliographic Details
Main Authors:	S. V. Nedogoda, E. V. Chumachok, A. A. Ledyaeva, V. V. Tsoma
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	hyperuricemia arterial hypertension pulse wave velocity losartan
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1958

Similar Items

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Comparison of the effect of losartan versus candasartan on uric acid levels in hypertensive patients
by: Zeina A Munim Al-Thanoon
Published: (2019-06-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
by: S. V. Nedogoda, et al.
Published: (2005-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs
by: S. V. Nedogoda, et al.
Published: (2019-02-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome
by: S. V. Nedogoda, et al.
Published: (2006-04-01)

EFFICACY OF A FIXED COMBINATION OF LOSARTAN AND AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION: SEASONAL FEATURES
by: M. D. Smirnova, et al.
Published: (2017-06-01)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension
by: S. V. Nedogoda, et al.
Published: (2020-12-01)

Pulse wave velocity in arterial hypertension patients
by: O. A. Nazarova, et al.
Published: (2007-04-01)

MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF THE MAIN ARTERIES AND PULSE WAVE VELOCITY IN OLDER AGE INDIVIDUALS WITH ARTERIAL HYPERTENSION
by: G. G. Efremushkin, et al.
Published: (2014-08-01)

ADDITIONAL ANGIOPROTECTION AND METAbOLIC DISORDERS CORRECTION IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS REACHED TARGET bLOOD PRESSURE LEVELS, WITH FIxED COMbINATION OF PERINDOPRIL AND INDAPAMIDE
by: S. V. Nedogod, et al.
Published: (2018-05-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

OPTIMAL ORGANOPROTECTION, CONTROL OF bLOOD PRESSURE AND METAbOLIC DISORDER WITH THE FIxED COMbINATION OF LISINOPRIL, AMLODIPINE AND ROSUVASTATIN IN SYSTEMIC HYPERTENSION
by: S. V. Nedogoda, et al.
Published: (2018-05-01)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

Inflammaging and Vascular Function in Metabolic Syndrome: The Role of Hyperuricemia
by: Agnė Laučytė-Cibulskienė, et al.
Published: (2022-03-01)

INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. V. Egorkina, et al.
Published: (2016-01-01)

AORTIC STIFFNESS ASSESSMENT IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: E. Yu. Shupenina, et al.
Published: (2013-06-01)

A COMPARISON OF THE MAIN ANTIHYPERTENSIVE DRUGS FROM THE VIEWPOINT OF AORTIC STIFFNESS MODIFICATION IN ARTERIAL HYPERTENSION
by: E. Yu. Shupenina, et al.
Published: (2014-04-01)

CHARACTERISTICS OF RENIN PROFILE AND PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH PREVIOUSLY UNTREATED HYPERTENSION
by: O. A. Kravtsova, et al.
Published: (2015-09-01)

Relationship between components of metabolic syndrome and arterial stiffness in Chinese hypertensives
by: Jin Gong, et al.
Published: (2020-02-01)

ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Influence of losartan on structural and functional remodelling of cardiovascular system in comorbidity of chronic obstructive lung disease and arterial hypertension
by: V. A. Nikitin, et al.
Published: (2016-10-01)

Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up
by: Paolo Meani, et al.
Published: (2018-01-01)

Polymorbidity and indicators of carbohydrate, lipid and purine metabolism in patients with arterial hypertension
by: Yu. A. Nikolaev, et al.
Published: (2021-08-01)

Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
by: Pertseva N.O., et al.
Published: (2013-06-01)

Mildronate effects on cognitive function in elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2012-10-01)

POLYMORPHISM OF THE MATRIX METALLOPROTEASES 2 AND 9 AND AORTIC STIFFNESS IN ADULTS WITH ARTERIAL HYPERTENSION
by: A. V. Sakovskaya, et al.
Published: (2017-04-01)

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01)

MICROALBUMINURIA AS A FORECAST FACTOR FOR CARDIO-VASCULAR COMPLICATIONS AND A MARKER OF THERAPY EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva, et al.
Published: (2016-01-01)

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
by: S. V. Nedogoda, et al.
Published: (2020-08-01)